Ocular Behçet Disease—Clinical Manifestations, Treatments and Outcomes According to Age at Disease Onset

Behçet disease (BD) is a multisystemic disease that commonly involves the eyes. Although it affects patients in all age groups, data on ocular disease by age of onset are limited. This retrospective, multicenter study aimed to compare epidemiology, systemic and ocular manifestations, treatments and...

Full description

Bibliographic Details
Main Authors: Michael Ostrovsky, Amir Rosenblatt, Salam Iriqat, Abdallah Shteiwi, Yael Sharon, Michal Kramer, Vicktoria Vishnevskia-Dai, Shaul Sar, Yosif Boulos, Oren Tomkins-Netzer, Natalie Lavee, Yael Ben-Arie-Weintrob, Hadas Pizem, Tamar Hareuveni-Blum, Marina Schneck, Raz Gepstein, Dua Masarwa, Nakhoul Nakhoul, Erez Bakshi, Shiri Shulman, Michaella Goldstein, Dan Ramon, Marina Anouk, Zohar Habot-Wilner
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/11/2/624
_version_ 1797622170339246080
author Michael Ostrovsky
Amir Rosenblatt
Salam Iriqat
Abdallah Shteiwi
Yael Sharon
Michal Kramer
Vicktoria Vishnevskia-Dai
Shaul Sar
Yosif Boulos
Oren Tomkins-Netzer
Natalie Lavee
Yael Ben-Arie-Weintrob
Hadas Pizem
Tamar Hareuveni-Blum
Marina Schneck
Raz Gepstein
Dua Masarwa
Nakhoul Nakhoul
Erez Bakshi
Shiri Shulman
Michaella Goldstein
Dan Ramon
Marina Anouk
Zohar Habot-Wilner
author_facet Michael Ostrovsky
Amir Rosenblatt
Salam Iriqat
Abdallah Shteiwi
Yael Sharon
Michal Kramer
Vicktoria Vishnevskia-Dai
Shaul Sar
Yosif Boulos
Oren Tomkins-Netzer
Natalie Lavee
Yael Ben-Arie-Weintrob
Hadas Pizem
Tamar Hareuveni-Blum
Marina Schneck
Raz Gepstein
Dua Masarwa
Nakhoul Nakhoul
Erez Bakshi
Shiri Shulman
Michaella Goldstein
Dan Ramon
Marina Anouk
Zohar Habot-Wilner
author_sort Michael Ostrovsky
collection DOAJ
description Behçet disease (BD) is a multisystemic disease that commonly involves the eyes. Although it affects patients in all age groups, data on ocular disease by age of onset are limited. This retrospective, multicenter study aimed to compare epidemiology, systemic and ocular manifestations, treatments and outcomes between three age groups: juvenile (<18 years), adult (18–39 years) and late (≥40 years) disease onset. The study included 175 ocular BD patients (303 eyes) from Israel and Palestine: juvenile-onset (<i>n</i> = 25, 14.3%), adult-onset (<i>n</i> = 120, 68.6%) and late-onset (<i>n</i> = 30, 17.1%). Most patients in all groups were male. Systemic manifestations were similar in all groups. Systemic co-morbidities were more common in late-onset patients. Bilateral panuveitis was the most common ocular manifestation in all patients. Non-occlusive retinal vasculitis, peripheral vessel occlusions, cataract and elevated intraocular pressure were found more commonly among juvenile-onset eyes. Anterior uveitis and macular ischemia were most common among late-onset eyes, while branch retinal vein occlusion was most common in adult and late-onset eyes. All patients were treated with corticosteroids. Methotrexate, immunomodulatory combinations and biologic treatments were more commonly used for juvenile-onset patients. All groups had a similar visual outcome. Our study showed that patients with ocular BD have varied ocular manifestations and require different treatments according to age of disease onset, but visual outcome is similar.
first_indexed 2024-03-11T09:06:31Z
format Article
id doaj.art-f93da6fa7ce14fba9e219bf8cb2066ab
institution Directory Open Access Journal
issn 2227-9059
language English
last_indexed 2024-03-11T09:06:31Z
publishDate 2023-02-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj.art-f93da6fa7ce14fba9e219bf8cb2066ab2023-11-16T19:21:00ZengMDPI AGBiomedicines2227-90592023-02-0111262410.3390/biomedicines11020624Ocular Behçet Disease—Clinical Manifestations, Treatments and Outcomes According to Age at Disease OnsetMichael Ostrovsky0Amir Rosenblatt1Salam Iriqat2Abdallah Shteiwi3Yael Sharon4Michal Kramer5Vicktoria Vishnevskia-Dai6Shaul Sar7Yosif Boulos8Oren Tomkins-Netzer9Natalie Lavee10Yael Ben-Arie-Weintrob11Hadas Pizem12Tamar Hareuveni-Blum13Marina Schneck14Raz Gepstein15Dua Masarwa16Nakhoul Nakhoul17Erez Bakshi18Shiri Shulman19Michaella Goldstein20Dan Ramon21Marina Anouk22Zohar Habot-Wilner23Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, IsraelSackler Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, IsraelSt. John of Jerusalem Eye Hospital Group, East Jerusalem 91198, PalestineSt. John of Jerusalem Eye Hospital Group, East Jerusalem 91198, PalestineSackler Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, IsraelSackler Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, IsraelSackler Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, IsraelDepartment of Ophthalmology, Carmel Medical Center, The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa 3436212, IsraelDepartment of Ophthalmology, Carmel Medical Center, The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa 3436212, IsraelDepartment of Ophthalmology, Carmel Medical Center, The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa 3436212, IsraelDepartment of Ophthalmology, HaEmek Medical Center, The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa 183411, IsraelDepartment of Ophthalmology, Rambam Medical Center, The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa 3525408, IsraelDepartment of Ophthalmology, Rambam Medical Center, The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa 3525408, IsraelDepartment of Ophthalmology, Galilee Medical Center, Azrieli Faculty of Medicine, Bar-Ilan University, Galilee 22100, IsraelDepartment of Ophthalmology, Soroka University Medical Center, Ben-Gurion University of the Negev, Beer-Sheva 84101, IsraelSackler Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, IsraelDepartment of Ophthalmology, Barzilai Medical Center, Ashkelon, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheba 7830604, IsraelDepartment of Ophthalmology, Baruch Padeh Medical Center, Azrieli Faculty of Medicine, Bar-Ilan University, Galilee 15280, IsraelSackler Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, IsraelOphthalmology institute, Assuta Medical Centers, Tel Aviv 6789140, IsraelSackler Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, IsraelSackler Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, IsraelSackler Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, IsraelSackler Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, IsraelBehçet disease (BD) is a multisystemic disease that commonly involves the eyes. Although it affects patients in all age groups, data on ocular disease by age of onset are limited. This retrospective, multicenter study aimed to compare epidemiology, systemic and ocular manifestations, treatments and outcomes between three age groups: juvenile (<18 years), adult (18–39 years) and late (≥40 years) disease onset. The study included 175 ocular BD patients (303 eyes) from Israel and Palestine: juvenile-onset (<i>n</i> = 25, 14.3%), adult-onset (<i>n</i> = 120, 68.6%) and late-onset (<i>n</i> = 30, 17.1%). Most patients in all groups were male. Systemic manifestations were similar in all groups. Systemic co-morbidities were more common in late-onset patients. Bilateral panuveitis was the most common ocular manifestation in all patients. Non-occlusive retinal vasculitis, peripheral vessel occlusions, cataract and elevated intraocular pressure were found more commonly among juvenile-onset eyes. Anterior uveitis and macular ischemia were most common among late-onset eyes, while branch retinal vein occlusion was most common in adult and late-onset eyes. All patients were treated with corticosteroids. Methotrexate, immunomodulatory combinations and biologic treatments were more commonly used for juvenile-onset patients. All groups had a similar visual outcome. Our study showed that patients with ocular BD have varied ocular manifestations and require different treatments according to age of disease onset, but visual outcome is similar.https://www.mdpi.com/2227-9059/11/2/624Behçet diseaseocular Behçet diseasejuvenile-onset Behçet diseaseadult-onset Behçet diseaselate-onset Behçet diseaseBehçet uveitis
spellingShingle Michael Ostrovsky
Amir Rosenblatt
Salam Iriqat
Abdallah Shteiwi
Yael Sharon
Michal Kramer
Vicktoria Vishnevskia-Dai
Shaul Sar
Yosif Boulos
Oren Tomkins-Netzer
Natalie Lavee
Yael Ben-Arie-Weintrob
Hadas Pizem
Tamar Hareuveni-Blum
Marina Schneck
Raz Gepstein
Dua Masarwa
Nakhoul Nakhoul
Erez Bakshi
Shiri Shulman
Michaella Goldstein
Dan Ramon
Marina Anouk
Zohar Habot-Wilner
Ocular Behçet Disease—Clinical Manifestations, Treatments and Outcomes According to Age at Disease Onset
Biomedicines
Behçet disease
ocular Behçet disease
juvenile-onset Behçet disease
adult-onset Behçet disease
late-onset Behçet disease
Behçet uveitis
title Ocular Behçet Disease—Clinical Manifestations, Treatments and Outcomes According to Age at Disease Onset
title_full Ocular Behçet Disease—Clinical Manifestations, Treatments and Outcomes According to Age at Disease Onset
title_fullStr Ocular Behçet Disease—Clinical Manifestations, Treatments and Outcomes According to Age at Disease Onset
title_full_unstemmed Ocular Behçet Disease—Clinical Manifestations, Treatments and Outcomes According to Age at Disease Onset
title_short Ocular Behçet Disease—Clinical Manifestations, Treatments and Outcomes According to Age at Disease Onset
title_sort ocular behcet disease clinical manifestations treatments and outcomes according to age at disease onset
topic Behçet disease
ocular Behçet disease
juvenile-onset Behçet disease
adult-onset Behçet disease
late-onset Behçet disease
Behçet uveitis
url https://www.mdpi.com/2227-9059/11/2/624
work_keys_str_mv AT michaelostrovsky ocularbehcetdiseaseclinicalmanifestationstreatmentsandoutcomesaccordingtoageatdiseaseonset
AT amirrosenblatt ocularbehcetdiseaseclinicalmanifestationstreatmentsandoutcomesaccordingtoageatdiseaseonset
AT salamiriqat ocularbehcetdiseaseclinicalmanifestationstreatmentsandoutcomesaccordingtoageatdiseaseonset
AT abdallahshteiwi ocularbehcetdiseaseclinicalmanifestationstreatmentsandoutcomesaccordingtoageatdiseaseonset
AT yaelsharon ocularbehcetdiseaseclinicalmanifestationstreatmentsandoutcomesaccordingtoageatdiseaseonset
AT michalkramer ocularbehcetdiseaseclinicalmanifestationstreatmentsandoutcomesaccordingtoageatdiseaseonset
AT vicktoriavishnevskiadai ocularbehcetdiseaseclinicalmanifestationstreatmentsandoutcomesaccordingtoageatdiseaseonset
AT shaulsar ocularbehcetdiseaseclinicalmanifestationstreatmentsandoutcomesaccordingtoageatdiseaseonset
AT yosifboulos ocularbehcetdiseaseclinicalmanifestationstreatmentsandoutcomesaccordingtoageatdiseaseonset
AT orentomkinsnetzer ocularbehcetdiseaseclinicalmanifestationstreatmentsandoutcomesaccordingtoageatdiseaseonset
AT natalielavee ocularbehcetdiseaseclinicalmanifestationstreatmentsandoutcomesaccordingtoageatdiseaseonset
AT yaelbenarieweintrob ocularbehcetdiseaseclinicalmanifestationstreatmentsandoutcomesaccordingtoageatdiseaseonset
AT hadaspizem ocularbehcetdiseaseclinicalmanifestationstreatmentsandoutcomesaccordingtoageatdiseaseonset
AT tamarhareuveniblum ocularbehcetdiseaseclinicalmanifestationstreatmentsandoutcomesaccordingtoageatdiseaseonset
AT marinaschneck ocularbehcetdiseaseclinicalmanifestationstreatmentsandoutcomesaccordingtoageatdiseaseonset
AT razgepstein ocularbehcetdiseaseclinicalmanifestationstreatmentsandoutcomesaccordingtoageatdiseaseonset
AT duamasarwa ocularbehcetdiseaseclinicalmanifestationstreatmentsandoutcomesaccordingtoageatdiseaseonset
AT nakhoulnakhoul ocularbehcetdiseaseclinicalmanifestationstreatmentsandoutcomesaccordingtoageatdiseaseonset
AT erezbakshi ocularbehcetdiseaseclinicalmanifestationstreatmentsandoutcomesaccordingtoageatdiseaseonset
AT shirishulman ocularbehcetdiseaseclinicalmanifestationstreatmentsandoutcomesaccordingtoageatdiseaseonset
AT michaellagoldstein ocularbehcetdiseaseclinicalmanifestationstreatmentsandoutcomesaccordingtoageatdiseaseonset
AT danramon ocularbehcetdiseaseclinicalmanifestationstreatmentsandoutcomesaccordingtoageatdiseaseonset
AT marinaanouk ocularbehcetdiseaseclinicalmanifestationstreatmentsandoutcomesaccordingtoageatdiseaseonset
AT zoharhabotwilner ocularbehcetdiseaseclinicalmanifestationstreatmentsandoutcomesaccordingtoageatdiseaseonset